Efficacy of goshajinkigan for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients

Efficacy of goshajinkigan for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients - Efficacy of goshajinkigan for peripheral neuropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009956

Enrollment

Registered

2013-02-05

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Colorectal cancer patients (N = 29) who received &#8805;4 weeks of goshajinkigan for oxaliplatin-induced peripheral neuropathy during chemotherapy at Kyoto Prefectural University of Medicine

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

Measure	Time frame
The effect of goshajinkigan was graded as curative, effective, stabilizing, or deleterious. The relationships between grade of peripheral neuropathy and dose of oxaliplatin in the goshajinkigan and non-goshajinkigan groups were evaluated.	—

Secondary

Measure	Time frame
complication	—

Countries

Japan

Outcome results